We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
+$146M
Cap. Flow %
3.08%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162
Avg Time Held Equity + Options
3.8 quarters
Top 10 Avg Time Held Equity + Options
1.1 quarters
Top 20 Avg Time Held Equity + Options
1.1 quarters
Avg Time Held Equity only
3.9 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.68%
3 Financials 11.99%
4 Miscellaneous 10.5%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SCYX icon
351
SCYNEXIS
SCYX
$40.1M
$1.14M 0.02%
48,252
-24,957
-34% -$583K
2022 Q2
4 quarters
LRMR icon
352
Larimar Therapeutics
LRMR
$263M
$1.14M 0.02%
363,505
+151,011
+71% +$616K
2022 Q4
2 quarters
THRX
353
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$1.13M 0.02%
121,452
+10,737
+10% +$106K
2023 Q1
1 quarter
VSTM icon
354
Verastem
VSTM
$747M
$1.12M 0.02%
150,904
+103,677
+220% +$720K
2022 Q1
5 quarters
KPTI icon
355
Karyopharm Therapeutics
KPTI
$11.5M
$1.09M 0.02%
40,447
+860
+2% +$37K
2022 Q1
5 quarters
EWTX icon
356
Edgewise Therapeutics
EWTX
$4.18B
$1.08M 0.02%
139,858
+6,890
+5% +$58.1K
2022 Q2
4 quarters
DISH
357
PUT
DELISTED
DISH Network Corp.
DISH
$1.08M 0.02%
126,400
– –
2021 Q2
8 quarters
DCPH icon
358
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.08M 0.02%
76,737
+18,042
+31% +$258K
2022 Q3
3 quarters
CABA icon
359
Cabaletta Bio
CABA
$303M
$1.05M 0.02%
81,332
+36,332
+81% +$394K
2023 Q1
1 quarter
CP icon
360
Canadian Pacific Kansas City
CP
$75.2B
$1.05M 0.02%
+12,985
New +$1.03M
2023 Q2
0 quarters
MTCH icon
361
Match Group
MTCH
$9.53B
$1.05M 0.02%
25,000
+18,260
+271% +$668K
2023 Q1
1 quarter
MEOH icon
362
Methanex
MEOH
$4.77B
$1.03M 0.02%
+25,000
New +$1.08M
2023 Q2
0 quarters
SKIL icon
363
Skillsoft
SKIL
$57M
$1.03M 0.02%
41,682
– –
2021 Q2
8 quarters
CPAY icon
364
Corpay
CPAY
$26.1B
$1.03M 0.02%
+4,100
New +$935K
2023 Q2
0 quarters
CRNX icon
365
DELISTED
Crinetics Pharmaceuticals
CRNX
$1.01M 0.02%
56,153
+22,732
+68% +$453K
2022 Q1
5 quarters
BKI
366
DELISTED
Black Knight, Inc. Common Stock
BKI
$975K 0.02%
16,329
+12,169
+293% +$683K
2023 Q1
1 quarter
HWEL
367
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$950K 0.02%
92,441
-2,084
-2% -$21.3K
2021 Q4
6 quarters
ATXS icon
368
DELISTED
Astria Therapeutics
ATXS
$950K 0.02%
+114,000
New +$1.32M
2023 Q2
0 quarters
EVLVW icon
369
DELISTED
Evolv Technologies Warrant
EVLVW
$943K 0.02%
693,200
-15,685
-2% -$15.2K
2021 Q3
7 quarters
ACAH
370
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$936K 0.02%
90,632
-2,042
-2% -$20.8K
2021 Q4
6 quarters
RZLT icon
371
Rezolute
RZLT
$471M
$935K 0.02%
472,307
+41,832
+10% +$86.2K
2023 Q1
1 quarter
STAA icon
372
STAAR Surgical
STAA
$1.1B
$928K 0.02%
17,650
-8,965
-34% -$546K
2023 Q1
1 quarter
ARE icon
373
Alexandria Real Estate Equities
ARE
$7.59B
$925K 0.02%
8,150
+870
+12% +$104K
2022 Q1
5 quarters
TSLA icon
374
Tesla
TSLA
$1.49T
$916K 0.02%
3,500
+2,500
+250% +$500K
2021 Q2
8 quarters
CGEM icon
375
Cullinan Oncology
CGEM
$962M
$915K 0.02%
+85,000
New +$903K
2023 Q2
0 quarters
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor deployed $146M of net new capital in Q2 2023, opening 128 new positions and adding to 150 existing holdings. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Tower Semiconductor, an estimated $50.8M trimmed.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.